Further analysis revealed that FEFS + /FS had a lower frequency of null mutation than MCD or other focal epilepsies; and missense mutations associated with FEFS + /FS were located away from the binding sites to NPRL2/NPRL3 or RAGA/RAGC. The gene discussed is NPRL2; the disease is focal epilepsy.